134 related articles for article (PubMed ID: 36461607)
1. Fibronectin 1 derived from tumor-associated macrophages and fibroblasts promotes metastasis through the JUN pathway in hepatocellular carcinoma.
Zhang L; Zhang C; Xing Z; Lou C; Fang J; Wang Z; Li M; He H; Bai H
Int Immunopharmacol; 2022 Dec; 113(Pt A):109420. PubMed ID: 36461607
[TBL] [Abstract][Full Text] [Related]
2. M2 Macrophage-Derived Exosomes Facilitate HCC Metastasis by Transferring α
Wu J; Gao W; Tang Q; Yu Y; You W; Wu Z; Fan Y; Zhang L; Wu C; Han G; Zuo X; Zhang Y; Chen Z; Ding W; Li X; Lin F; Shen H; Tang J; Zhang Y; Wang X
Hepatology; 2021 Apr; 73(4):1365-1380. PubMed ID: 32594528
[TBL] [Abstract][Full Text] [Related]
3. Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma.
Mo Z; Liu D; Chen Y; Luo J; Li W; Liu J; Yu L; Huang B; Zhang S
J Transl Med; 2022 Oct; 20(1):466. PubMed ID: 36221095
[TBL] [Abstract][Full Text] [Related]
4. Glycogen metabolism-mediated intercellular communication in the tumor microenvironment influences liver cancer prognosis.
Zhang Y; Qin N; Wang X; Liang R; Liu Q; Geng R; Jiang T; Liu Y; Li J
Oncol Res; 2024; 32(3):563-576. PubMed ID: 38361757
[TBL] [Abstract][Full Text] [Related]
5. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
Wu S; Zheng Q; Xing X; Dong Y; Wang Y; You Y; Chen R; Hu C; Chen J; Gao D; Zhao Y; Wang Z; Xue T; Ren Z; Cui J
J Exp Clin Cancer Res; 2018 May; 37(1):99. PubMed ID: 29728125
[TBL] [Abstract][Full Text] [Related]
6. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
[TBL] [Abstract][Full Text] [Related]
7. Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma.
Yang F; Wei Y; Han D; Li Y; Shi S; Jiao D; Wu J; Zhang Q; Shi C; Yang L; Song W; Zhang J; Han Y; Zhang R; Yang AG; Dimitrov DS; Zhao A; Qin W; Wen W
Cancer Res; 2020 Sep; 80(18):3892-3905. PubMed ID: 32591411
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
9. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
[TBL] [Abstract][Full Text] [Related]
10. The interactions between integrin α
Peng Z; Hao M; Tong H; Yang H; Huang B; Zhang Z; Luo KQ
Int J Biol Sci; 2022; 18(13):5019-5037. PubMed ID: 35982891
[TBL] [Abstract][Full Text] [Related]
11. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data.
Yu L; Shen N; Shi Y; Shi X; Fu X; Li S; Zhu B; Yu W; Zhang Y
Front Immunol; 2022; 13():1009789. PubMed ID: 36211448
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Evidence Reveals that Cell Cycle Correlated Genes Drive the Communication between Tumor Cells and the Tumor Microenvironment and Impact the Outcomes of Hepatocellular Carcinoma.
Chen D; Feng Z; Zhou M; Ren Z; Zhang F; Li Y
Biomed Res Int; 2021; 2021():4092635. PubMed ID: 34746301
[TBL] [Abstract][Full Text] [Related]
15. Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma.
Su Z; He Y; You L; Zhang G; Chen J; Liu Z
Front Immunol; 2024; 15():1363834. PubMed ID: 38633247
[TBL] [Abstract][Full Text] [Related]
16. EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin.
Liu Z; Chen D; Ning F; Du J; Wang H
J Cell Biochem; 2018 May; 119(5):4170-4183. PubMed ID: 29315755
[TBL] [Abstract][Full Text] [Related]
17. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
Cui ZH; Shen SQ; Chen ZB; Hu C
World J Gastroenterol; 2014 May; 20(18):5493-504. PubMed ID: 24833879
[TBL] [Abstract][Full Text] [Related]
19. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion.
Yang J; Xing Z
Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Luo JP; Wang J; Huang JH
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34405225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]